Ripertamab

Names

[ Name ]:
Ripertamab

Biological Activity

[Description]:

Ripertamab (SCT400) is a recombinant, human-mouse chimeric anti-CD20 IgG1κ mAb. Ripertamab can be used for the research of hematological malignancies, including non-Hodgkin’s lymphoma (NHL)[1].

[Related Catalog]:

Research Areas >> Cancer

[References]

[1]. Kaplon H, et al. Antibodies to watch in 2022. MAbs. 2022 Jan-Dec;14(1):2014296.

Chemical & Physical Properties

No Any Chemical & Physical Properties